Alphatec Holdings, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Patrick S. Miles
- Full Time Employees
- 913
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 1950 Camino Vida Roble Carlsbad CA United States of America 92008
- IPO Date
- Jun 1, 2006
- CIK
- 0001350653
- Website
- atecspine.com
- Similar Companies
- Business
- Alphatec Holdings, Inc. (Nasdaq: ATEC) develops, manufactures and markets innovative surgical solutions for spine disorders, focusing on comprehensive procedural approaches that integrate implants, biologics, neuromonitoring and imaging technologies to enhance surgical safety, predictability and patient outcomes; its core products include the PTP Prone Transpsoas and ALIF procedural solutions, spinal implant systems such as Invictus fixation and IdentiTi Porous Titanium interbody devices, SafeOp Neural InformatiX automated nerve monitoring system, biologics like AlphaGRAFT DBM and Amnioshield, and EOSedge low-dose biplanar imaging integrated into the AlphaInformatiX platform. Founded in 1990 and headquartered in Carlsbad, California, the company operates primarily in the United States through a direct sales force targeting spine surgeons, hospitals and ambulatory surgery centers. Recent developments include the launch of Calibrate NanoTec CCX parallel expanding interbody spacers for TLIF and PLIF approaches, reporting Q3 2025 revenue of $197 million with 30% year-over-year growth, raising full-year 2025 revenue guidance, and sustained procedural adoption driving profitability improvements.
Company News
Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Alphatec (ATEC) Q2 Earnings Lag Estimates
Alphatec Q2 Earnings Call Highlights
ATEC Reports Second Quarter Financial Results
ATEC Announces Participation in Upcoming Investor Conferences
ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026
Alphatec Holdings Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
ALPHATEC INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Alphatec Holdings, Inc. on Behalf of Alphatec Stockholders and Encourages Investors to Contact the Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATEC
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm